Search Results for “aging” – Page 105 – media

Scotland’s Synpromics expands gene therapy work with UCL deal

Edinburgh, Scotland based Synpromics has teamed up with UCL Great Ormond Street Institute of Child Health to develop novel gene therapies for diseases affecting the haematopoietic system.
- Source: drugdu
- 500
- January 29, 2018
cell and gene therapy haematopoietic immune system novel gene-based medicines UCL
NICE/PHE against blanket use of antibiotics for sore throats

Sore throats should be treated with painkillers and not antibiotics, according to new guidelines produced by the National Institute for Health and Care Excellence and Public Health England. According to NICE, antibiotics are prescribed to treat sore throats in 60 percent of cases, but evidence shows that the majority of people will get better without them.
- Source: pharmatimes
- 621
- January 29, 2018
antibiotics NICE NIH painkiller polices Sore throats
Neuroscientists Have Followed a Thought as it Moves Through the Brain

A study using epilepsy patients undergoing surgery has given neuroscientists an opportunity to track in unprecedented detail the movement of a thought through the human brain, all the way from inspiration to response.
- Source: Futurism
- 634
- January 26, 2018
brain epilepsy neuroscience Researches
AstraZeneca’s PARP Inhibitor Lynparza Gets Approval in Japan

AstraZeneca AZN and partner Merck MRK announced that the Japanese Ministry of Health, Labour and Welfare has granted approval to its PARP inhibitor, Lynparza, as a maintenance therapy for relapsed ovarian cancer, irrespective of BRCA mutation status in patients who have responded to their last platinum-based chemotherapy.
- Source: finance.yahoo
- 678
- January 26, 2018
cancer inhibitor New Approvals ovarian
Spark Therapeutics Enters into a Licensing and Supply Agreement for Investigational Voretigene Neparvovec Outside the U.S.

Spark Therapeutics (ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced it has entered into a licensing agreement with Novartis Pharmaceuticals to develop and commercialize investigational voretigene neparvovec outside the U.S.
- Source: finance.yahoo
- 532
- January 26, 2018
Gene therapy Market Views voretigene neparvovec
Boosting cancer therapy with cross-dressed immune cells

Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods. Immunotherapies are breakthrough treatments that stimulate the patient’s immune cells to attack the tumor through the recognition of aberrant molecules called tumor antigens. They can be very effective, but currently can only cure a minority of patients with solid tumors. Researchers and physicians are now looking into ways of increasing the precision and strength of the immune attack on the tumor. Dendritic cell vaccines One approach is the “dendritic cell vaccine”. Dendritic cells are specialized immune cells whose role is to capture antigens from foreign bodies and present them to the immune system’s killer T cells, which will then attack and destroy the invaders. For the vaccine, dendritic cells are taken out of the patient, “force-fed” with tumor antigens, and finally re-injected back into ...
- Source: medicalxpress
- 584
- January 25, 2018
artificial molecules cancer tumor immunotherapies Researches
China’s digital healthcare transformation – private hospital achieve HIMSS milestone

Explosive growth and groundbreaking digital transformations are underway in China’s enormous healthcare market, and now a Beijing hospital has become the first private healthcare organisation in the nation to achieve Stage 6 on the HIMSS EMRAM scale for its electronic medical record system.
- Source: Healthcare IT
- 531
- January 25, 2018
China health IT healthcare Market Views
Leaf Healthcare touts reduced pressure injuries in Leaf wearable sensor study

Patient monitoring system developer Leaf Healthcare today released results from a study exploring the ability of its Leaf wearable patient sensor to prevent pressure injuries on acutely ill adults, touting that patients were 73% less likely to develop such injuries when monitored with the device.
- Source: Mass Device
- 612
- January 24, 2018
medical device Researches wearables
GSK, Pfizer lead in new global Twitter pharma influencer ranking

Tweeting to the top, GlaxoSmithKline and Pfizer tied for the No. 1 spot in the inaugural ranking of global pharma influencers by Owen Health. The U.K.-based healthcare marketing agency evaluated 22 pharma companies on authority, reach, activity, engagement and influence to rate the most and least adept when it comes to Twitter.
- Source: fiercepharma
- 626
- January 23, 2018
global pharma influencers GSK Pfizer
Digital currency-based fitness app Sweatcoin lands $5.7M in funding

Earning a little extra toward workout products and fitness classes could be as easy as tracking the steps you take outside. London-based Sweatcoin, a company which “pays” users a digital currency based on their daily steps, has just landed $5.7 million in a funding round led by Goodwater Capital with participation from Seedcamp, Greylock Partners, Rubylight, SmartHub, and several angel investors.
- Source: Mobile Health News
- 650
- January 23, 2018
blockchain Company Insight digital health mHealth

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.